Home > > > Report Detail

Global Blood Plasma Market (Immunoglobulin, Albumin, Factor VIII, & Alpha 1): Insights, Trends and Forecast (2019-2023)

Publisher Name :
Date: 30-Jul-2019
No. of pages: 109
Inquire Before Buying

The global blood plasma market is estimated to reach US$29.50 billion in 2023, growing at a CAGR of 7% for the period spanning from 2019 to 2023. The factors such as progress in therapeutic protein development, new advances in production of plasma, growing aging population, increasing spending on medicines and rise in collection centers are expected to drive the market. However, growth of the industry will be challenged by high cost of treatment, and high R&D costs. A few notable trends include increase in fractionation capacity, and innovation in therapeutics.

The global blood plasma market is broadly segmented into four types which are Immunoglobulin, Albumin, Factor VIII, Alpha 1 and Others. Increased recognition and treatment of primary immunodeficiency (PI), use in new indications, and increasing consumption in low IG-use countries has driven the growth of immunoglobulin segment.

North America is the largest market for blood plasma due to its advanced infrastructure which has helped in increasing plasma collection over the time. The emerging economies like China have showed huge potential with increased imports of Albumin. Rising use of immunoglobulin and increasing incidence of immune and bleeding disorders propelled the demand for immunoglobulin in the Unites States.

Scope of the report:


  • The report provides a comprehensive analysis of the global blood plasma market, segmented into Immunoglobulin, Albumin, Factor VIII, Alpha 1 and Others.

  • The major regional markets (North America, Europe and APAC) have been analyzed, along with country coverage of the United States.

  • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.

  • The competitive landscape of the market, along with the company profiles of leading players (Takeda Pharmaceutical, CSL Limited, Grifols S.A., Octapharma, Inc., ADMA Biologics and China Biologics) are also presented in detail.


Key Target Audience:


  • Blood Plasma Products Manufacturers

  • End Users (Hospitals, Medical Centers & Clinical Institutes)

  • Consulting Firms

  • Investment Banks

  • Government Bodies & Regulating Authorities

Global Blood Plasma Market (Immunoglobulin, Albumin, Factor VIII, & Alpha 1): Insights, Trends and Forecast (2019-2023)

Table of Contents

1. Market Overview
1.1 Blood Plasma
1.2 Blood Plasma Fractionation Process
1.3 Blood Plasma Derivatives
1.4 Functions of Blood Plasma
1.5 Plasma Collection

2. Global Market Analysis
2.1 Global Blood Plasma Market by Value
2.2 Global Blood Plasma Market Forecast by Value
2.3 Global Blood Plasma Fractionation Capacity
2.4 Global Blood Plasma Fractionation Capacity Forecast
2.5 Global Blood Plasma Fractionation Capacity by Type
2.6 Global Blood Plasma Fractionation Capacity Forecast by Type
2.7 Global Blood Plasma Market by Type
2.8 Global Blood Plasma Market Forecast by Type
2.9 Global Immunoglobulin Market
2.9.1 Global Immunoglobulin Market Forecast by Value
2.9.2 Global Immunoglobulin Market Forecast by Volume
2.9.3 Global Immunoglobulin Market Volume by Region
2.9.4 Global Immunoglobulin Market by Types
2.9.5 Global Immunoglobulin Population by Indication
2.10 Global Albumin Market
2.10.1 Global Albumin Market Forecast by Value
2.10.2 Global Albumin Market Forecast by Volume
2.10.3 Global Albumin Market Volume by Region
2.11 Global Factor VIII Market
2.11.1 Global Factor VIII Market Forecast by Value
2.11.2 Global Factor VIII Market Forecast by Volume
2.12 Global Alpha 1 Market
2.12.1 Global Alpha 1 Market Forecast by Value
2.13 Global Blood Plasma Market by Region

3. Regional Analysis
3.1 North America
3.1.1 North America Blood Plasma Market Forecast by Value
3.1.2 North America Blood Plasma Market by Type
3.1.3 The US Immunoglobulin Market Forecast by Value & Volume
3.1.4 The US Immunoglobulin Market Volume by Segment
3.1.5 The US Albumin Market Forecast by Volume
3.1.6 The US Source Plasma Collection Volume
3.1.7 The US Source Plasma Collection Volume Forecast
3.2 Europe
3.2.1 Europe Blood Plasma Market Forecast by Value
3.3 APAC
3.3.1 Asia-Pacific Blood Plasma Market Forecast by Value

4. Market Dynamics
4.1 Growth Drivers
4.1.1 Recent Progress in Therapeutic Protein Drug Development
4.1.2 Developments in the Production of Plasma Derivatives
4.1.3 Increasing Plasma Collection
4.1.4 Increase in Per Capita use of Immunoglobulin
4.1.5 Rise in GDP Per Capita
4.1.6 Increased Spending on Medicines
4.1.7 Increasing Global Healthcare Expenditure
4.1.8 Escalating Ageing Population
4.2 Trends & Developments
4.2.1 Increasing Fractionation Capacity
4.2.2 Growing Blood Plasma Market in Emerging Economies
4.3 Challenges & Issues
4.3.1 High Barriers to Entry
4.3.2 Challenging to Open New Plasma Centers
4.3.3 High R&D Costs

5. Competitive Landscape
5.1 Global Market
5.1.1 Revenue and Market Cap Comparison
5.1.2 Research & Development Expenditure Comparison
5.1.3 Global Blood Plasma Market Share
5.1.4 Global Immunoglobulin Market Share
5.1.5 Global Albumin Market Share
5.1.6 Global Plasma-Derived Factor VIII Market Share
5.1.7 Global Alpha1 Market Share
5.1.8 Growth in Plasma Collection by Leading Players
5.2 The US
5.2.1 The US Blood Plasma Collection Centers by Major Players
5.2.2 The US Blood Plasma Collection Volume by Major Players

6. Company Profiles
6.1 Takeda Pharmaceutical (Shire Plc.)
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 CSL Limited
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Grifols, S.A.
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 Octapharma, Inc.
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies
6.5 ADMA Biologics, Inc.
6.5.1 Business Overview
6.5.2 Financial Overview
6.5.3 Business Strategies
6.6 China Biologics Product Holdings
6.6.1 Business Overview
6.6.2 Financial Overview
6.6.3 Business Strategies

List of Tables

Blood Plasma Protein Breakup
Functions of Blood Plasma
Protein Engineering Platform Technologies (2018)
The US Food and Drug Administration-Approved IG Products (2018)
Fractionation Capacity of Key Market Players (2013-2022)
Key Players - Revenue & Market Cap Comparison (2018)
Key Players - Research & Development Expenditure Comparison (2018)

List of Figures

Components of Blood Plasma
Blood Plasma Fractionation Process
Plasma Fractioned to Protein
Global Blood Plasma Market by Value (2014-2018)
Global Blood Plasma Market Forecast by Value (2019-2023)
Global Blood Plasma Fractionation Capacity (2014-2018)
Global Blood Plasma Fractionation Capacity Forecast (2019-2023)
Global Blood Plasma Fractionation Capacity by Type (2014-2018)
Global Blood Plasma Fractionation Capacity Forecast by Type (2019-2023)
Global Blood Plasma Market by Type (2018)
Global Blood Plasma Market Forecast by Type (2023)
Global Immunoglobulin Market Forecast by Value (2018-2023)
Global Immunoglobulin Market Forecast by Volume (2018-2023)
Global Immunoglobulin Market Volume by Region (2018)
Global Immunoglobulin Market by Types (2018)
Global Immunoglobulin Population by Indication (2018)
Global Albumin Market Forecast by Value (2018-2023)
Global Albumin Market Forecast by Volume (2018-2023)
Global Albumin Market Volume by Region (2018)
Global Factor VIII Market Forecast by Value (2018-2023)
Global Factor VIII Market Forecast by Volume (2018-2023)
Global Alpha 1 Market Forecast by Value (2018-2023)
Global Blood Plasma Market by Region (2018)
North America Blood Plasma Market Forecast by Value (2018-2023)
North America Blood Plasma Market by Type (2018)
The US Immunoglobulin Market Forecast by Value & Volume (2018-2023)
The US Immunoglobulin Market Volume by Segment (2018)
The US Albumin Market Forecast by Volume (2018-2023)
The US Source Plasma Collection Volume (2014-2018)
The US Source Plasma Collection Volume Forecast (2019-2023)
Europe Blood Plasma Market Forecast by Value (2018-2023)
Asia-Pacific Blood Plasma Market Forecast by Value (2018-2023)
Plasma Collection in the US (2014-2018)
Per Capita use of Immunoglobulin by Region (2018)
Global GDP Per Capita (2014-2018)
Global Spending on Medicines (2010-2020)
Global Healthcare Expenditure (2014-2018)
Global Ageing Population of 60 Years or Older (2014-2018)
Global Blood Plasma Market Share by Company (2018)
Global Immunoglobulin Market Share by Company (2018)
Global Albumin Market Share by Company (2018)
Global Plasma-Derived Factor VIII Market Share by Company (2018)
Global Alpha1 Market Share by Company (2018)
Growth in Plasma Collection by Leading Players (2014-2018)
The US Blood Plasma Collection Centers by Major Players (2014-2018)
The US Blood Plasma Collection Volume by Major Players (2014-2018)
Takeda Pharmaceutical Revenue Share by Product (2019)
Takeda Pharmaceutical Revenue Share by Geographic Region (2019)
Takeda Pharmaceutical Revenue and Net Profit (2015-2019)
CSL Limited Revenue Share by Segments (2018)
CSL Limited Sales and Net Profit (2014-2018)
Grifols, S.A. Revenue Share by Business Segments (2018)
Grifols, S.A. Revenue Share by Geographic Region (2018)
Grifols, S.A. Revenue and Profit (2014-2018)
Octapharma, Inc. Revenue and Net Profit (2014-2018)
ADMA Biologics Revenue Share by Business Segments (2018)
ADMA Biologics Revenue and Net Loss (2014-2018)
China Biologics Revenue Share by Business Segments (2018)
China Biologics Revenue and Net Income (2014-2018)

  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs